Stephen J.LurieMD, PhD, Senior EditorIndividualAuthorJody W.ZylkeMD, Contributing EditorIndividualAuthor
Copyright 2001 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2001
In Reply: I admire Dr Dermksian's confidence
in the "inherent intelligence" and "rigorous scientific and clinical training,"
which he believes allow practitioners to "make appropriate judgments of industry-supported
CME." Would that it were true, but experienced medical educators know that
most busy clinicians do not have the time or the training to evaluate the
research literature for themselves and must depend on the opinions of unbiased
experts. Neither CME speakers paid by the drug companies nor the sales representatives
who work for the companies can be considered unbiased. If their presentations
did not put the company's products in a favorable light, why would companies
invest billions of dollars in activities that did not serve their commercial
Relman AS. The Pharmaceutical Industry and Continuing Education—Reply. JAMA. 2001;286(3):302-304. doi:10.1001/jama.286.3.302